Oxidative stress damage as a detrimental factor in preterm birth pathology

Frontiers in Immunology

Volumn 5, Issue NOV, 2014, Pages

  Menon, Ramkumar ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Inflammation; Oxidative damage; Oxidative stress; Premature rupture of fetal membranes; Preterm birth; Senescence; Senescence associated secretory phenotype

Indexed keywords

2 AMINOPURINE; 3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; 8 HYDROXYGUANINE; ANTIOXIDANT; CATALASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROSTANE DERIVATIVE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ADVERSE OUTCOME; AMNIONITIS; BIRTH; DNA CROSS LINKING; DNA DAMAGE; EPIGENETICS; FEMALE; GENETIC HETEROGENEITY; HUMAN; INFLAMMATION; MALNUTRITION; OBESITY; OXIDATIVE STRESS; PATHOLOGY; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PROTEIN DEGRADATION; REVIEW; SENESCENCE; SMOKING; SYSTEMATIC REVIEW; TELOMERE SHORTENING; UTERUS CONTRACTION;

EID: 84919331850     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00567     Document Type: Review

References (135)

1. Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ (2010) 88(1):31-8. doi: 10.2471/BLT.08.062554
2. Behrman RE, Butler AS, editors. Preterm Birth: Causes, Consequences, and Prevention. Washington, DC: National Academies Press (US) (2007).
3. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet (2008) 371(9606):75-84. doi:10.1016/S0140-6736(08)60074-4
4. Goldenberg RL, Gravett MG, Iams J, Papageorghiou AT, Waller SA, Kramer M, et al. The preterm birth syndrome: issues to consider in creating a classification system. Am J Obstet Gynecol (2012) 206(2):113-8. doi:10.1016/j.ajog.2011.10.865
5. Gomez R, Romero R, Edwin SS, David C. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. Infect Dis Clin North Am (1997) 11(1):135-76. doi:10.1016/S0891-5520(05)70347-0
6. Menon R. Spontaneous preterm birth, a clinical dilemma: etiologic, pathophysiologic and genetic heterogeneities and racial disparity. Acta Obstet Gynecol Scand (2008) 87(6):590-600. doi:10.1080/00016340802005126
7. Mercer BM, Lewis R. Preterm labor and preterm premature rupture of the membranes. Diagnosis and management. Infect Dis Clin North Am (1997) 11(1):177-201. doi:10.1016/S0891-5520(05)70348-2
8. Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R, et al. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol (1989) 161(3):817-24. doi:10.1016/0002-9378(89)90409-2
9. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel LA, Nien JK. Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med (2006) 11(5):317-26. doi:10.1016/j.siny.2006.05.001
10. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, et al. The preterm parturition syndrome. BJOG (2006) 113(Suppl 3):17-42. doi:10.1111/j.1471-0528.2006.01120.x
11. Creasy RK, Merkatz IR. Prevention of preterm birth: clinical opinion. Obstet Gynecol (1990) 76(1 Suppl):2S-4S.
12. Di Renzo GC, Al SE, Mattei A, Koutras I, Clerici G. Use of tocolytics: what is the benefit of gaining 48 hours for the fetus? BJOG (2006) 113(Suppl 3):72-7. doi:10.1111/j.1471-0528.2006.01127.x
13. Elliott JP, Morrison JC. The evidence regarding maintenance tocolysis. Obstet Gynecol Int (2013) 2013:708023. doi:10.1155/2013/708023
14. Grimes DA, Nanda K. Magnesium sulfate tocolysis: time to quit. Obstet Gynecol (2006) 108(4):986-9. doi:10.1097/01.AOG.0000236445.18265.93
15. Hill WC, Gookin KS. Home uterine activity monitoring. Clin Perinatol (1992) 19(2):333-43.
16. Iams JD, Johnson FF, O'Shaughnessy RW, West LC. A prospective random trial of home uterine activity monitoring in pregnancies at increased risk of preterm labor. Am J Obstet Gynecol (1987) 157(3):638-43. doi:10.1016/S0002-9378(87)80020-0
17. Kenyon AP, Peebles D. Myth: tocolysis for prevention of preterm birth has a major role in modern obstetrics. Semin Fetal Neonatal Med (2011) 16(5):242-6. doi:10.1016/j.siny.2011.04.008
18. Lyell DJ, Pullen KM, Mannan J, Chitkara U, Druzin ML, Caughey AB, et al. Maintenance nifedipine tocolysis compared with placebo: a randomized controlled trial. Obstet Gynecol (2008) 112(6):1221-6. doi:10.1097/AOG.0b013e31818d8386
19. Mercer BM, Merlino AA. Magnesium sulfate for preterm labor and preterm birth. Obstet Gynecol (2009) 114(3):650-68. doi:10.1097/AOG.0b013e3181b48336
20. Morrison JC, Martin JN Jr, Martin RW, Gookin KS, Wiser WL. Prevention of preterm birth by ambulatory assessment of uterine activity: a randomized study. Am J Obstet Gynecol (1987) 156(3):536-43. doi:10.1016/0002-9378(87)90046-9
21. Nassar AH, Aoun J, Usta IM. Calcium channel blockers for the management of preterm birth: a review. Am J Perinatol (2011) 28(1):57-66. doi:10.1055/s-0030-1262512
22. Norwitz ER, Robinson JN. A systematic approach to the management of preterm labor. Semin Perinatol (2001) 25(4):223-35. doi:10.1053/sper.2001.26417
23. Olson DM, Christiaens I, Gracie S, Yamamoto Y, Mitchell BF. Emerging tocolytics: challenges in designing and testing drugs to delay preterm delivery and prolong pregnancy. Expert Opin Emerg Drugs (2008) 13(4):695-707. doi:10.1517/14728210802568764
24. Owen P, Patel N. Prevention of preterm birth. Baillieres Clin Obstet Gynaecol (1995) 9(3):465-79. doi:10.1016/S0950-3552(05)80375-X
25. Usta IM, Khalil A, Nassar AH. Oxytocin antagonists for the management of preterm birth: a review. Am J Perinatol (2011) 28(6):449-60. doi:10.1055/s-0030-1270111
26. da Fonseca EB, Damiao R, Nicholaides K. Prevention of preterm birth based on short cervix: progesterone. Semin Perinatol (2009) 33(5):334-7. doi:10.1053/j.semperi.2009.06.006
27. Dodd JM, Flenady VJ, Cincotta R, Crowther CA. Progesterone for the prevention of preterm birth: a systematic review. Obstet Gynecol (2008) 112(1):127-34. doi:10.1097/AOG.0b013e31817d0262
28. Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol (2011) 38(1):18-31. doi:10.1002/uog.9017
29. Romero R, Yeo L, Miranda J, Hassan SS, Conde-Agudelo A, Chaiworapongsa T. A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix. J Perinat Med (2013) 41(1):27-44. doi:10.1515/jpm-2012-0272
30. van Os MA, van der Ven JA, Kleinrouweler CE, Pajkrt E, de Miranda E, van Wassenaer A, et al. Preventing preterm birth with progesterone: costs and effects of screening low risk women with a singleton pregnancy for short cervical length, the Triple P study. BMC Pregnancy Childbirth (2011) 11:77. doi:10.1186/1471-2393-11-77
31. Aina-Mumuney AJ, Rai KK, Taylor MY, Weitz CM, Chisholm CA. Nulliparity and duration of pregnancy in multiple gestation. Obstet Gynecol (2004) 104(1):110-3. doi:10.1097/01.AOG.0000128905.37143.47
32. Guinn DA, Wigton TR, Owen J, Socol ML, Frederiksen MC. Prediction of preterm birth in nulliparous patients. Am J Obstet Gynecol (1994) 171(4):1111-5. doi:10.1016/S0002-9378(13)90046-6
33. Mercer BM, Goldenberg RL, Meis PJ, Moawad AH, Shellhaas C, Das A, et al. The Preterm Prediction Study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol (2000) 183(3):738-45. doi:10.1067/mob.2000.106766
34. Miranda ML, Edwards SE, Myers ER. Adverse birth outcomes among nulliparous vs. multiparous women. Public Health Rep (2011) 126(6):797-805.
35. Rajasingam D, Seed PT, Briley AL, Shennan AH, Poston L. A prospective study of pregnancy outcome and biomarkers of oxidative stress in nulliparous obese women. Am J Obstet Gynecol (2009) 200(4):395-9. doi:10.1016/j.ajog.2008.10.047
36. Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med (2010) 362(14):1282-91. doi:10.1056/NEJMoa0908056
37. Xiong X, Fraser WD, Demianczuk NN. History of abortion, preterm, term birth, and risk of preeclampsia: a population-based study. Am J Obstet Gynecol (2002) 187(4):1013-8. doi:10.1067/mob.2002.126282
38. Romero R, Mazor M, Wu YK, Sirtori M, Oyarzun E, Mitchell MD, et al. Infection in the pathogenesis of preterm labor. Semin Perinatol (1988) 12(4):262-79.
39. Romero R, Espinoza J, Chaiworapongsa T, Kalache K. Infection and prematurity and the role of preventive strategies. Semin Neonatol (2002) 7(4):259-74. doi:10.1053/siny.2002.0121
40. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S. The role of inflammation and infection in preterm birth. Semin Reprod Med (2007) 25(1):21-39. doi:10.1055/s-2006-956773
41. Menon R, Taylor RN, Fortunato SJ. Chorioamnionitis - a complex pathophysiologic syndrome. Placenta (2010) 31(2):113-20. doi:10.1016/j.placenta.2009.11.012
42. Abrahams VM, Potter JA, Bhat G, Peltier MR, Saade G, Menon R. Bacterial modulation of human fetal membrane toll-like receptor expression. Am J Reprod Immunol (2013) 69(1):33-40. doi:10.1111/aji.12016
43. Bhat G, Peltier MR, Syed TA, Drobek CO, Saade G, Menon R. Fetal membrane biomarker network diversity and disease functions induced by intra-amniotic pathogens. Am J Reprod Immunol (2013) 69(2):124-33. doi:10.1111/aji.12047
44. Menon R, Peltier MR, Eckardt J, Fortunato SJ. Diversity in cytokine response to bacteria associated with preterm birth by fetal membranes. Am J Obstet Gynecol (2009) 201(3):306. doi:10.1016/j.ajog.2009.06.027
45. Peltier MR, Drobek CO, Bhat G, Saade G, Fortunato SJ, Menon R. Amniotic fluid and maternal race influence responsiveness of fetal membranes to bacteria. J Reprod Immunol (2012) 96(1-2):68-78. doi:10.1016/j.jri.2012.07.006
46. Agarwal A, Aponte-Mellado A, Premkumar BJ, Shaman A, Gupta S. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol (2012) 10(1):49. doi:10.1186/1477-7827-10-49
47. Dennery PA. Oxidative stress in development: nature or nurture? Free Radic Biol Med (2010) 49(7):1147-51. doi:10.1016/j.freeradbiomed.2010.07.011
48. Halliwell B, Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J (1984) 219(1):1-14.
49. Myatt L. Review: reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta (2010) 31(Suppl):S66-9. doi:10.1016/j.placenta.2009.12.021
50. Sies H. Oxidative stress: from basic research to clinical application. Am J Med (1991) 91(3C):31S-8S. doi:10.1016/0002-9343(91)90281-2
51. Finkel T. Signal transduction by reactive oxygen species. J Cell Biol (2011) 194(1):7-15. doi:10.1083/jcb.201102095
52. Cadenas E, Sies H. Oxidative stress: excited oxygen species and enzyme activity. Adv Enzyme Regul (1985) 23:217-37. doi:10.1016/0065-2571(85)90049-4
53. Durackova Z. Some current insights into oxidative stress. Physiol Res (2010) 59(4):459-69.
54. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol (2004) 142(2):231-55. doi:10.1038/sj.bjp.0705776
55. Vercesi AE, Kowaltowski AJ, Oliveira HC, Castilho RF. Mitochondrial Ca2+ transport, permeability transition and oxidative stress in cell death: implications in cardiotoxicity, neurodegeneration and dyslipidemias. Front Biosci (2006) 11:2554-64. doi:10.2741/1990
56. Bandy B, Davison AJ. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Radic Biol Med (1990) 8(6):523-39. doi:10.1016/0891-5849(90)90152-9
57. Basaran A, Basaran M, Topatan B. Combined vitamin C and E supplementation for the prevention of preeclampsia: a systematic review and meta-analysis. Obstet Gynecol Surv (2010) 65(10):653-67. doi:10.1097/OGX.0b013e3182095366
58. Conde-Agudelo A, Romero R, Kusanovic JP, Hassan SS. Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol (2011) 204(6):503-12. doi:10.1016/j.ajog.2011.02.020
59. Dror DK, Allen LH. Interventions with vitamins B6, B12 and C in pregnancy. Paediatr Perinat Epidemiol (2012) 26(Suppl 1):55-74. doi:10.1111/j.1365-3016.2012.01277.x
60. Rossi AC, Mullin PM. Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis. Eur J Obstet Gynecol Reprod Biol (2011) 158(1):9-16. doi:10.1016/j.ejogrb.2011.04.010
61. Thorne-Lyman AL, Fawzi WW. Vitamin A and carotenoids during pregnancy and maternal, neonatal and infant health outcomes: a systematic review and meta-analysis. Paediatr Perinat Epidemiol (2012) 26(Suppl 1):36-54. doi:10.1111/j.1365-3016.2012.01284.x
62. Sies H. Strategies of antioxidant defense. Eur J Biochem (1993) 215(2):213-9. doi:10.1111/j.1432-1033.1993.tb18025.x
63. McKersie BD, Bowley SR, Harjanto E, Leprince O. Water-deficit tolerance and field performance of transgenic Alfalfa overexpressing superoxide dismutase. Plant Physiol (1996) 111(4):1177-81.
64. Sigler K, Chaloupka J, Brozmanova J, Stadler N, Hofer M. Oxidative stress in microorganisms - I. Microbial vs. higher cells - damage and defenses in relation to cell aging and death. Folia Microbiol (Praha) (1999) 44(6):587-624. doi:10.1007/BF02825650
65. Morrow JD, Roberts LJ. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res (1997) 36(1):1-21. doi:10.1016/S0163-7827(97)00001-5
66. Richter C, Park JW, Ames BN. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci U S A (1988) 85(17):6465-7. doi:10.1073/pnas.85.17.6465
67. Adelman R, Saul RL, Ames BN. Oxidative damage to DNA: relation to species metabolic rate and life span. Proc Natl Acad Sci U S A (1988) 85(8):2706-8. doi:10.1073/pnas.85.8.2706
68. Fraga CG, Shigenaga MK, Park JW, Degan P, Ames BN. Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci U S A (1990) 87(12):4533-7. doi:10.1073/pnas.87.12.4533
69. Subash P, Gurumurthy P, Sarasabharathi A, Cherian KM. Urinary 8-OHdG: a marker of oxidative stress to DNA and total antioxidant status in essential hypertension with South Indian population. Indian J Clin Biochem (2010) 25(2):127-32. doi:10.1007/s12291-010-0024-z
70. Peter Stein T, Scholl TO, Schluter MD, Leskiw MJ, Chen X, Spur BW, et al. Oxidative stress early in pregnancy and pregnancy outcome. Free Radic Res (2008) 42(10):841-8. doi:10.1080/10715760802510069
71. Chen HI, Liou SH, Ho SF, Wu KY, Sun CW, Chen MF, et al. Oxidative DNA damage estimated by plasma 8-hydroxydeoxyguanosine (8-OHdG): influence of 4, 4'-methylenebis (2-chloroaniline) exposure and smoking. J Occup Health (2007) 49(5):389-98. doi:10.1539/joh.49.389
72. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta (2004) 339(1-2):1-9. doi:10.1016/j.cccn.2003.09.010
73. Matsubasa T, Uchino T, Karashima S, Kondo Y, Maruyama K, Tanimura M, et al. Oxidative stress in very low birth weight infants as measured by urinary 8-OHdG. Free Radic Res (2002) 36(2):189-93. doi:10.1080/10715760290006510
74. Tsukahara H, Haruta T, Ono N, Kobata R, Fukumoto Y, Hiraoka M, et al. Oxidative stress in childhood meningitis: measurement of 8-hydroxy-2'-deoxyguanosine concentration in cerebrospinal fluid. Redox Rep (2000) 5(5):295-8. doi:10.1179/135100000101535834
75. Tarng DC, Huang TP, Wei YH, Liu TY, Chen HW, Wen Chen T, et al. 8-Hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis (2000) 36(5):934-44. doi:10.1053/ajkd.2000.19086
76. Marczynski B, Kraus T, Rozynek P, Raithel HJ, Baur X. Association between 8-hydroxy-2'-deoxyguanosine levels in DNA of workers highly exposed to asbestos and their clinical data, occupational and non-occupational confounding factors, and cancer. Mutat Res (2000) 468(2):203-12. doi:10.1016/S1383-5718(00)00053-X
77. Chen L, Bowen PE, Berzy D, Aryee F, Stacewicz-Sapuntzakis M, Riley RE. Diet modification affects DNA oxidative damage in healthy humans. Free Radic Biol Med (1999) 26(5-6):695-703. doi:10.1016/S0891-5849(98)00254-8
78. Leinonen J, Lehtimäki T, Toyokuni S, Okada K, Tanaka T, Hiai H, et al. New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett (1997) 417(1):150-2. doi:10.1016/S0014-5793(97)01273-8
79. Daube H, Scherer G, Riedel K, Ruppert T, Tricker AR, Rosenbaum P, et al. DNA adducts in human placenta in relation to tobacco smoke exposure and plasma antioxidant status. J Cancer Res Clin Oncol (1997) 123(3):141-51. doi:10.1007/s004320050042
80. Kaneko T, Tahara S, Matsuo M. Non-linear accumulation of 8-hydroxy-2'-deoxyguanosine, a marker of oxidized DNA damage, during aging. Mutat Res (1996) 316(5-6):277-85. doi:10.1016/S0921-8734(96)90010-7
81. Menon R, Boldogh I, Hawkins HK, Woodson M, Polettini J, Syed TA, et al. Histological evidence of oxidative stress and premature senescence in preterm premature rupture of the human fetal membranes recapitulated in vitro. Am J Pathol (2014) 184(6):1740-51. doi:10.1016/j.ajpath.2014.02.011
82. Menon R, Fortunato SJ, Milne GL, Brou L, Carnevale C, Sanchez SC, et al. Amniotic fluid eicosanoids in preterm and term births: effects of risk factors for spontaneous preterm labor. Obstet Gynecol (2011) 118(1):121-34. doi:10.1097/AOG.0b013e3182204eaa
83. Menon R, Yu J, Basanta-Henry P, Brou L, Berga SL, Fortunato SJ, et al. Short fetal leukocyte telomere length and preterm prelabor rupture of the membranes. PLoS One (2012) 7(2):e31136. doi:10.1371/journal.pone.0031136
84. Menon R, Boldogh I, Urrabaz-Garza R, Polettini J, Syed TA, Saade GR, et al. Senescence of primary amniotic cells via oxidative DNA damage. PLoS One (2013) 8(12):e83416. doi:10.1371/journal.pone.0083416
85. de LT. Protection of mammalian telomeres. Oncogene (2002) 21(4):532-40. doi:10.1038/sj.onc.1205080
86. Iyama T, Wilson DM III. DNA repair mechanisms in dividing and non-dividing cells. DNA Repair (Amst) (2013) 12(8):620-36. doi:10.1016/j.dnarep.2013.04.015
87. Hazra TK, Das A, Das S, Choudhury S, Kow YW, Roy R. Oxidative DNA damage repair in mammalian cells: a new perspective. DNA Repair (Amst) (2007) 6(4):470-80. doi:10.1016/j.dnarep.2006.10.011
88. Klungland A, Bjelland S. Oxidative damage to purines in DNA: role of mammalian Ogg1. DNA Repair (Amst) (2007) 6(4):481-8. doi:10.1016/j.dnarep.2006.10.012
89. Jiang YL, Ichikawa Y, Song F, Stivers JT. Powering DNA repair through substrate electrostatic interactions. Biochemistry (2003) 42(7):1922-9. doi:10.1021/bi027014x
90. Dherin C, Dizdaroglu M, Doerflinger H, Boiteux S, Radicella JP. Repair of oxidative DNA damage in Drosophila melanogaster: identification and characterization of dOgg1, a second DNA glycosylase activity for 8-hydroxyguanine and formamidopyrimidines. Nucleic Acids Res (2000) 28(23):4583-92. doi:10.1093/nar/28.23.4583
91. Hajas G, Bacsi A, Aguilera-Aguirre L, Hegde ML, Tapas KH, Sur S, et al. 8-Oxoguanine DNA glycosylase-1 links DNA repair to cellular signaling via the activation of the small GTPase Rac1. Free Radic Biol Med (2013) 61C:384-94. doi:10.1016/j.freeradbiomed.2013.04.011
92. Hill JW, Hazra TK, Izumi T, Mitra S. Stimulation of human 8-oxoguanine-DNA glycosylase by AP-endonuclease: potential coordination of the initial steps in base excision repair. Nucleic Acids Res (2001) 29(2):430-8. doi:10.1093/nar/29.2.430
93. Rodier F, Muñoz DP, Teachenor R, Chu V, Le O, Bhaumik D, et al. DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J Cell Sci (2011) 124(Pt 1):68-81. doi:10.1242/jcs.071340
94. Beliveau A, Bassett E, Lo AT, Garbe J, Rubio MA, Bissell MJ, et al. p53-dependent integration of telomere and growth factor deprivation signals. Proc Natl Acad Sci U S A (2007) 104(11):4431-6. doi:10.1073/pnas.0700260104
95. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature (2003) 426(6963):194-8. doi:10.1038/nature02118
96. Tsolou A, Passos JF, Nelson G, Arai Y, Zglinicki T. ssDNA fragments induce cell senescence by telomere uncapping. Exp Gerontol (2008) 43(10):892-9. doi:10.1016/j.exger.2008.08.043
97. Rodríguez-Vargas JM, Ruiz-Magaña MJ, Ruiz-Ruiz C, Majuelos-Melguizo J, Peralta-Leal A, Rodríguez MI, et al. ROS-induced DNA damage and PARP-1 are required for optimal induction of starvation-induced autophagy. Cell Res (2012) 22(7):1181-98. doi:10.1038/cr.2012.70
98. Scherle PA, Jones EA, Favata MF, Daulerio AJ, Covington MB, Nurnberg SA, et al. Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J Immunol (1998) 161(10):5681-6.
99. Brancho D, Tanaka N, Jaeschke A, Ventura JJ, Kelkar N, Tanaka Y, et al. Mechanism of p38 MAP kinase activation in vivo. Genes Dev (2003) 17(16):1969-78. doi:10.1101/gad.1107303
100. Torres M. Mitogen-activated protein kinase pathways in redox signaling. Front Biosci (2003) 8:d369-91. doi:10.2741/999
101. Cuenda A, Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta (2007) 1773(8):1358-75. doi:10.1016/j.bbamcr.2007.03.010
102. Thornton TM, Rincon M. Non-classical p38 map kinase functions: cell cycle checkpoints and survival. Int J Biol Sci (2009) 5(1):44-51. doi:10.7150/ijbs.5.44
103. Natale DR, Paliga AJ, Beier F, D'Souza SJ, Watson AJ. p38 MAPK signaling during murine preimplantation development. Dev Biol (2004) 268(1):76-88. doi:10.1016/j.ydbio.2003.12.011
104. Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol (2010) 5:99-118. doi:10.1146/annurev-pathol-121808-102144
105. Menon R, Fortunato SJ. Infection and the role of inflammation in preterm premature rupture of the membranes. Best Pract Res Clin Obstet Gynaecol (2007) 21(3):467-78. doi:10.1016/j.bpobgyn.2007.01.008
106. Fox H. Aging of the placenta. Arch Dis Child Fetal Neonatal Ed (1997) 77(3):F171-5. doi:10.1136/fn.77.3.F171
107. Campisi J. Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes. Exp Gerontol (2003) 38(1-2):5-11. doi:10.1016/S0531-5565(02)00152-3
108. Davalos AR, Coppe JP, Campisi J, Desprez PY. Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev (2010) 29(2):273-83. doi:10.1007/s10555-010-9220-9
109. Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol (2008) 6(12):e301. doi:10.1371/journal.pbio.0060301
110. Romero R, Miranda J, Chaiworapongsa T, Korzeniewski SJ, Chaemsaithong P, Gotsch F, et al. Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Reprod Immunol (2014) 72:458-74. doi:10.1111/aji.12296
111. Hajas G, Bacsi A, Aguilerra-Aguirre L, German P, Radak Z, Sur S, et al. Biochemical identification of a hydroperoxide derivative of the free 8-oxo-7,8-dihydroguanine base. Free Radic Biol Med (2012) 52(4):749-56. doi:10.1016/j.freeradbiomed.2011.11.015
112. Fortini P, Pascucci B, Parlanti E, D'Errico M, Simonelli V, Dogliotti E. 8-Oxoguanine DNA damage: at the crossroad of alternative repair pathways. Mutat Res (2003) 531(1-2):127-39. doi:10.1016/j.mrfmmm.2003.07.004
113. Boiteux S, Radicella JP. The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys (2000) 377(1):1-8. doi:10.1006/abbi.2000.1773
114. Luo J, Hosoki K, Bacsi A, Radak Z, Hegde ML, Sur S, et al. 8-Oxoguanine DNA glycosylase-1-mediated DNA repair is associated with Rho GTPase activation and alpha-smooth muscle actin polymerization. Free Radic Biol Med (2014) 73:430-8. doi:10.1016/j.freeradbiomed.2014.03.030
115. Ba X, Bacsi A, Luo J, Aguilera-Aguirre L, Zeng X, Radak Z, et al. 8-Oxoguanine DNA glycosylase-1 augments proinflammatory gene expression by facilitating the recruitment of site-specific transcription factors. J Immunol (2014) 192(5):2384-94. doi:10.4049/jimmunol.1302472
116. German P, Szaniszlo P, Hajas G, Radak Z, Bacsi A, Hazra TK, et al. Activation of cellular signaling by 8-oxoguanine DNA glycosylase-1-initiated DNA base excision repair. DNA Repair (Amst) (2013) 12(10):856-63. doi:10.1016/j.dnarep.2013.06.006
117. Menon R, Polettini J, Syed TA, Saade GR, Boldogh I. Expression of 8-oxoguanine glycosylase in human fetal membranes. Am J Reprod Immunol (2014) 72:75-84. doi:10.1111/aji.12220
118. Fortunato SJ, Menon R, Bryant C, Lombardi SJ. Programmed cell death (apoptosis) as a possible pathway to metalloproteinase activation and fetal membrane degradation in premature rupture of membranes. Am J Obstet Gynecol (2000) 182(6):1468-76. doi:10.1067/mob.2000.107330
119. Fortunato SJ, Menon R, Lombardi SJ. Support for an infection-induced apoptotic pathway in human fetal membranes. Am J Obstet Gynecol (2001) 184(7):1392-7. doi:10.1067/mob.2001.115434
120. Fortunato SJ, Menon R. Distinct molecular events suggest different pathways for preterm labor and premature rupture of membranes. Am J Obstet Gynecol (2001) 184(7):1399-405. doi:10.1067/mob.2001.115122
121. Fortunato SJ, Menon R, Lombardi SJ. Role of tumor necrosis factor-alpha in the premature rupture of membranes and preterm labor pathways. Am J Obstet Gynecol (2002) 187(5):1159-62. doi:10.1067/mob.2002.127457
122. Fortunato SJ, Menon R. IL-1 beta is a better inducer of apoptosis in human fetal membranes than IL-6. Placenta (2003) 24(10):922-8. doi:10.1016/S0143-4004(03)00160-7
123. Menon R, Fortunato SJ, Yu J, Milne GL, Sanchez S, Drobek CO, et al. Cigarette smoke induces oxidative stress and apoptosis in normal term fetal membranes. Placenta (2011) 32(4):317-22. doi:10.1016/j.placenta.2011.01.015
124. Khanjani S, Kandola MK, Lindstrom TM, Sooranna SR, Melchionda M, Lee YS, et al. NF-kappaB regulates a cassette of immune/inflammatory genes in human pregnant myometrium at term. J Cell Mol Med (2011) 15(4):809-24. doi:10.1111/j.1582-4934.2010.01069.x
125. Lei K, Chen L, Georgiou EX, Sooranna SR, Khanjani S, Brosens JJ, et al. Progesterone acts via the nuclear glucocorticoid receptor to suppress IL-1beta-induced COX-2 expression in human term myometrial cells. PLoS One (2012) 7(11):e50167. doi:10.1371/journal.pone.0050167
126. Macintyre DA, Sykes L, Teoh TG, Bennett PR. Prevention of preterm labour via the modulation of inflammatory pathways. J Matern Fetal Neonatal Med (2012) 25(Suppl 1):17-20. doi:10.3109/14767058.2012.666114
127. Allport VC, Slater DM, Newton R, Bennett PR. NF-kappaB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol Hum Reprod (2000) 6(6):561-5. doi:10.1093/molehr/6.6.561
128. Olson DM, Ammann C. Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour. Front Biosci (2007) 12:1329-43. doi:10.2741/2151
129. Lappas M, Permezel M. The anti-inflammatory and antioxidative effects of nicotinamide, a vitamin B(3) derivative, are elicited by FoxO3 in human gestational tissues: implications for preterm birth. J Nutr Biochem (2011) 22(12):1195-201. doi:10.1016/j.jnutbio.2010.10.009
130. Chang EY, Zhang J, Sullivan S, Newman R, Singh I. N-acetylcysteine prevents preterm birth by attenuating the LPS-induced expression of contractile associated proteins in an animal model. J Matern Fetal Neonatal Med (2012) 25(11):2395-400. doi:10.3109/14767058.2012.697942
131. Casey ML, MacDonald PC. The endocrinology of human parturition. Ann N Y Acad Sci (1997) 828:273-84. doi:10.1111/j.1749-6632.1997.tb48548.x
132. Casey ML, Winkel CA, Porter JC, MacDonald PC. Endocrine regulation of the initiation and maintenance of parturition. Clin Perinatol (1983) 10(3):709-21.
133. Smith R, Nicholson RC. Corticotrophin releasing hormone and the timing of birth. Front Biosci (2007) 12:912-8. doi:10.2741/2113
134. Smith R. Alterations in the hypothalamic pituitary adrenal axis during pregnancy and the placental clock that determines the length of parturition. J Reprod Immunol (1998) 39(1-2):215-20. doi:10.1016/S0165-0378(98)00023-0
135. McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy. Nat Med (1995) 1(5):460-3. doi:10.1038/nm0595-460